Clicky

Oncodesign(ALONC)

Description: Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups. It offers integrated drug discovery services; in vitro and in vivo pharmacology services; services for studying the metabolism and pharmacokinetics of drug candidates; and translational biomarkers, biodecontamination/biosafety, and biobanking services. The company also engages in the analysis of new chemical and biological entities, and membrane proteins; and immuno analysis and monitoring, and microbiological monitoring activities. In addition, it engages in the kinase inhibitor development programs, and licensing of Kinase inhibitors in oncology, and CNS and inflammation technologies. Oncodesign Société Anonyme has a strategic partnership with InterSystems for new treatments in the field of oncology; and Covalab. The company also has a collaboration agreement with TiumBio Co., Ltd. for the research and development of fibrosis drug candidates. Oncodesign Société Anonyme was founded in 1995 and is headquartered in Dijon, France.


Keywords: Chemical Biopharmaceutical Drug Discovery Inflammation Cell Biology Biomarkers Fibrosis Pharmacokinetics Drug Discovery Services Pharmaceutical Firms

Home Page: www.oncodesign.com

20 rue Jean Mazen
Dijon, 21076
France
Phone: 33 3 80 78 82 60


Officers

Name Title
Dr. Philippe Genne Ph.D. Founder, Chairman, CEO & Chief Corp. Bus. Devel. Officer
Mr. Arnaud Lafforgue Chief Financial & Admin. Officer
Dr. Jan Hoflack Ph.D. Chief Scientific Officer, Deputy MD & Member of Exec. Board
Ms. Catherine Genne Deputy Managing Director, Member of the Exec. Board & Director
Mr. Olivier Duchamp Member of Exec. Board
Mr. Francis Bichat Member of Exec. Board
Ms. Karine Lignel Chief Operating Officer
Mr. Stephane Gerart Chief Information Officer & Head of Artificial Intelligence
Ms. Sylvie Fernandes Forster Chief Legal Officer
Mr. Thierry Billoue Chief HR Officer

Exchange: PA

Country: FR : France

Currency: Euro (€)

Forward PE: 0
Trailing PE: 63.2456
Price-to-Book MRQ: 19.0349
Price-to-Sales TTM: 3.0511
IPO Date:
Fiscal Year End: December
Full Time Employees: 230
Back to stocks